1997
DOI: 10.1111/j.1601-0825.1997.tb00340.x
|View full text |Cite
|
Sign up to set email alerts
|

Infections in hospitalised Russian children with AIDS

Abstract: The present chemoprophylaxis programme for opportunistic oral infections requires revision. Systems of microbiological surveillance and cross-infection control monitoring in relation to immunocompromised patients need to be developed to decrease the possibility of nosocomial transmission of potential pathogens between hospitalised children with AIDS, their mothers and health care providers.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2003
2003
2003
2003

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…The majority (54%) of the HIV-infected children were admitted to the Russia AIDS Centre with bacterial and fungal infections. The high prevalence of OPC in about half of them contributed to the decision to use azole drugs in their treatment (13). Fluconazole has been successful in treating OPC and esophageal candidiasis in HIV-infected patients (14,20,23), but its long-term use raises the possibility of the acquisition of resistance by the yeast Candida albicans (7,12,17,25) and the emergence of other Candida species, such as C. krusei and C. glabrata, with innately reduced susceptibilities to fluconazole (5,27).…”
mentioning
confidence: 99%
“…The majority (54%) of the HIV-infected children were admitted to the Russia AIDS Centre with bacterial and fungal infections. The high prevalence of OPC in about half of them contributed to the decision to use azole drugs in their treatment (13). Fluconazole has been successful in treating OPC and esophageal candidiasis in HIV-infected patients (14,20,23), but its long-term use raises the possibility of the acquisition of resistance by the yeast Candida albicans (7,12,17,25) and the emergence of other Candida species, such as C. krusei and C. glabrata, with innately reduced susceptibilities to fluconazole (5,27).…”
mentioning
confidence: 99%